Cardiovascular Safety of Xenon in General Anaesthesia, in Patient With Cardiovascular Risk in Non Cardiac Surgery

NCT01120405 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

600

Enrollment

INDUSTRY

Sponsor class

Conditions

Elevated Cardiac Risk
Coronary Arteries Disease Risk

Interventions

DRUG: Xenon
DRUG: Sevoflurane

Sponsor

Air Liquide Santé International

Collaborators

[object Object]
[object Object]
[object Object]